Skip to main content
MAYNE PHARMA GROUP LIMITED logo

MAYNE PHARMA GROUP LIMITED — Investor Relations & Filings

Ticker · MYX ISIN · AU000000MYX0 LEI · 549300VIRDEN0N4MJG59 ASX Manufacturing
Open in API
Filings indexed 1,121 across all filing types
Latest filing 2011-02-14 Director's Dealing
Country AU Australia
Listing ASX MYX

About MAYNE PHARMA GROUP LIMITED

https://www.maynepharma.com

Mayne Pharma Group Limited is a specialty pharmaceutical company focused on the development and commercialization of branded and generic medicines. The company operates through specialized segments including Women's Health and Dermatology. Its Women's Health portfolio features innovative contraceptive solutions, while the Dermatology division provides a broad range of treatments for various skin conditions. Beyond its product portfolio, the company provides contract development and manufacturing services (CDMO), leveraging proprietary drug delivery technologies to produce complex oral and topical dosage forms. The organization focuses on high-growth specialty markets, aiming to deliver differentiated therapeutic options and improve patient outcomes through technical excellence and strategic commercialization.

Recent filings

Filing Released Lang Actions
Change of Director`s Interest Notice 2 pages 105.4KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details changes in a director's relevant interests in securities, including the number of shares held before and after the change, the nature of the change, and consideration involved. This is a report of personal share transactions by company directors. The document length is 3138 characters, which is consistent with a detailed notice rather than a brief announcement. The content matches the definition of Director's Dealing filings, which report personal share transactions by company directors and executives (insider trades).
2011-02-14 English
Change of Director`s Interest Notice 2 pages 106.2KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details changes in securities holdings by a director, including number of shares held before and after the change, nature of the change, and consideration paid. This is a report of personal share transactions by a company director. The document length is 3511 characters, which is consistent with a detailed director's dealing notice. There is no indication that this is an annual report, audit report, or any other type of filing. Therefore, the document fits the definition of Director's Dealing (DIRS).
2011-02-14 English
Future Cash Flow Reporting 2 pages 72.2KB
Regulatory Filings Classification · 95% confidence The document is a short announcement from Mayne Pharma Group Limited regarding the cessation of the requirement to submit further Appendix 4C quarterly cash flow reports following four quarters of positive net operating cash flows. It contains no detailed financial statements, no comprehensive financial data, nor any detailed report content. The document is under 5,000 characters and reads as a regulatory announcement about compliance with ASX Listing Rules rather than a full financial report or detailed update. There is no indication of it being an earnings release, interim report, or any other detailed report type. Therefore, it fits best as a Regulatory Filing (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other categories.
2011-01-31 English
Change of Director`s Interest Notice 2 pages 34.4KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details changes in a director's relevant interests in securities, including the number of shares held before and after the change, nature of the change, and consideration. The document is 3270 characters long, which is relatively short and focused solely on director share transactions. This matches the definition of 'Director's Dealing' filings, which report personal share transactions by company directors and executives (insider trades). There is no indication that this is an annual report, audit report, or any other type of filing. Therefore, the correct classification is DIRS.
2011-01-31 English
Appendix 3B 7 pages 262.4KB
Capital/Financing Update Classification · 100% confidence The document is titled 'Appendix 3B' and is an announcement related to a new issue of securities, application for quotation of additional securities, and agreement. It includes details such as the class of securities issued, number of securities, issue price, purpose of the issue, and dates related to the securities. The document references ASX (Australian Securities Exchange) and provides detailed information about the securities issuance and quotation application. This type of document is a formal announcement of a capital raising or share issue event rather than a full financial report or earnings release. It fits the category of Capital/Financing Update (CAP) as it provides updates on company fundraising and capital structure changes.
2011-01-31 English
Roger Corbett appointed as Chairman 2 pages 99.7KB
Board/Management Information Classification · 100% confidence The document is a company announcement regarding the appointment of a new Chairman, Mr. Roger Corbett, at a recent Board meeting. It discusses the background and qualifications of the new Chairman and mentions corporate governance practices such as separating the CEO and Chairman roles. There is no financial data, no mention of a report or filing, and the content focuses on changes in senior management. The document length is short (3028 characters), and it is clearly an announcement of a board/management change rather than a report or regulatory filing. Therefore, the appropriate classification is Board/Management Information (MANG).
2011-01-27 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.